US Patent Issued to Angeles Therapeutics on Sept. 22 for "Diverse antigen binding domains, novel platforms and other enhancements for cellular therapy" (California Inventor)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,152, issued on Sept. 22, was assigned to Angeles Therapeutics Inc. (Toluca Lake, Calif.).

"Diverse antigen binding domains, novel platforms and other enhancements for cellular therapy" was invented by Preet M. Chaudhary (Toluca Lake, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides diverse antigen binding domains and platforms for construction of conventional and next generation chimeric antigen receptors for adoptive cellular therapies for cancer, infection, allergic, degenerative and immune disorders, Also provided are approaches for activation and expansion of immune T cells for adoptive cellular therapies for cancer...